Articles tagged with 'Export-CH' | Bayer

Newsroom Bayer (Export-CH)

2022
November
08,
2022
| 07:30 AM Europe/Amsterdam
Group sales increase by 5.7 percent (Fx & portfolio adj.) to 11.281 billion euros  / EBITDA before special items rises by 17.3 percent to 2.451 billion euros / Crop Science achieves strong sales gains – sales also up at Pharmaceuticals and Consumer H...
Read more
August
04,
2022
| 07:30 AM Europe/Amsterdam
Group sales increase by 9.6 percent (Fx & portfolio adj.) to 12.819 billion euros / EBITDA before special items rises by 30.0 percent to 3.349 billion euros / Crop Science and Consumer Health achieve strong sales and earnings growth / Pharmaceuticals...
Read more
August
02,
2022
| 08:45 AM Europe/Amsterdam
Empowering consumers to take more control over their own health means ensuring they have the knowledge and trust that products are safe and will work as described  / The Principles of Science-Led Self-Care paper forms a blueprint for the industry...
Read more
May
10,
2022
| 07:30 AM Europe/Amsterdam
Group sales grow by 14.3 percent (Fx & portfolio adj.) to 14.639 billion euros / EBITDA before special items increases by 27.5 percent to 5.251 billion euros / Substantial sales and earnings growth at Crop Science and Consumer Health / Sales up sligh...
Read more
February
02,
2022
| 11:00 AM Europe/Amsterdam
Basel, Switzerland, February 2, 2022 - Today Bayer announced Dr. Ricardo Salazar Hernández as the new Global Medical Affairs function with responsibilities over medical insights, claims and evidence strategies and generation, and health care professi...
Read more
2021
December
01,
2021
| 14:00 PM Europe/Amsterdam
The Consumer Health division accelerates the execution of its sustainability program and strikes partnership for collective action across the self care industry...
Read more
August
05,
2021
| 07:31 AM Europe/Amsterdam
Group sales increase by 12.9 percent (Fx & portfolio adj.) to 10.854 billion euros - double-digit percentage growth (Fx & portfolio adj.) at all divisions / EBITDA before special items declines by 10.6 percent to 2.577 billion euros, burdened by curr...
Read more
May
27,
2021
| 13:15 PM Europe/Amsterdam
Ada Health combines medical knowledge with powerful AI to revolutionize possibilities for personal health for patients globally / Investment to support advancement of Ada’s symptom assessment and care navigation platform...
Read more
May
12,
2021
| 07:30 AM Europe/Amsterdam
Good operational performance - sales and earnings negatively impacted by currency of 938 million euros and 337 million euros / Group sales up by 2.8 percent (Fx & portfolio adj.) to 12.328 billion euros / EBITDA before special items down 6.2 percent ...
Read more
February
02,
2021
| 14:00 PM Europe/Amsterdam
Primary Focus will be on Most Vulnerable - Pregnant Women and Children in Underserved Communities...
Read more
2020
November
17,
2020
| 16:30 PM Europe/Amsterdam
Deal deepens Bayer’s capabilities in the personalized healthcare and nutritionals space...
Read more
October
27,
2020
| 13:00 PM Europe/Amsterdam
Bayer launches Mission 1000+ campaign to empower parents with knowledge about the role of nutrition in their baby’s development...
Read more
October
15,
2020
| 13:00 PM Europe/Amsterdam
Harnessing the human skin microbiome to develop cutting-edge solutions moving the paradigm from treatment to cure in dermatology / Investment to support advancement of Azitra’s technology platform for both clinical and consumer programs...
Read more
2019
November
04,
2019
| 14:00 PM Europe/Amsterdam
Leverkusen, November 4, 2019 - Bayer announced today the completion of the sale of the Dr. Scholl’s™ business to Yellow Wood Partners for a purchase price of 585 million U.S. dollars. Dr. Scholl’s™ is an iconic, one-of-a-kind brand, which is synony...
Read more
September
02,
2019
| 11:00 AM Europe/Amsterdam
Divestiture enables Bayer to focus on core OTC business...
Read more
July
22,
2019
| 15:00 PM Europe/Amsterdam
Boston, Massachusetts, USA / Leverkusen, Germany, July 22, 2019 - Yellow Wood Partners and Bayer announced today that Yellow Wood Partners has entered into a definitive agreement to buy the Dr. Scholl’s™ business from Bayer for a purchase price of 58...
Read more
July
02,
2019
| 09:00 AM Europe/Amsterdam
Ballerup, Denmark / Leverkusen, Germany, July 2, 2019 - LEO Pharma and Bayer announced today the achievement of the relevant closing conditions to allow the transfer of Bayer’s global prescription dermatology business to LEO Pharma. The companies fir...
Read more
May
13,
2019
| 19:00 PM Europe/Amsterdam
Significant expansion of portfolio will advance Beiersdorf’s leading position as sun care expert / Beiersdorf delivers first major acquisition under its new C.A.R.E.+ strategy / Divestiture enables Bayer to focus on core OTC business...
Read more
2018
September
04,
2018
| 14:00 PM Europe/Amsterdam
Ballerup, Denmark / Leverkusen, Germany, September 4, 2018 - LEO Pharma and Bayer announced today the completion of the relevant closing conditions to allow the transfer of Bayer’s prescription dermatology business to LEO Pharma in the United States....
Read more
July
31,
2018
| 15:00 PM Europe/Amsterdam
Significant step to bolster LEO Pharma’s role as a leading global dermatology company with its goal of helping 125 million patients by 2025...
Read more
2017
November
15,
2017
| 08:30 AM Europe/Amsterdam
Erica Mann to leave Bayer effective March 31, 2018...
Read more